Your skin-lightening IV therapy awaits
What to watch Phase 1 readouts on first-in-human pharmacokinetics typically come 6 to 12 months after dosing starts
We did not observe significant differences in cell growth rates, where A2780 and A2780/GSTP1 cells had doubling times of 0.91 and 1.03 days, respectively ( P =0.462), or in cell cycle parameters, assessed by FACS analysis of propidium iodide-labelled untreated cells and stressed cells acutely treated with cisplatin (Figure 5A)
Fits when stress-triggered flushing rides alongside reactive skin
Dead volume (0.05mL to 0.1mL retained in the vial) must be accounted for by adding 510% extra bacteriostatic water beyond the calculated amount to ensure full dose availability across the research cycle
Stimuli were adjusted via current control from 0.04 mA to 3 mA (intervals of 0.01, 0.1, and 1 mA for each respective order of magnitude), and the maximal response was recorded